These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 413398)
1. Acute skin reactions in postoperative breast cancer patients receiving radiotherapy plus adjuvant chemotherapy. Hahn P; Hallberg O; Vikterlöf KJ AJR Am J Roentgenol; 1978 Jan; 130(1):137-9. PubMed ID: 413398 [TBL] [Abstract][Full Text] [Related]
2. Adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil, vincristine, and prednisone compared with single-agent L-phenylalanine mustard for patients with operable breast carcinoma and positive axillary lymph nodes: 20-year results of a Southwest Oncology Group study. Rivkin SE; Green SJ; Lew D; Costanzi JJ; Athens JW; Osborne CK; Vaughn CB; Martino S Cancer; 2003 Jan; 97(1):21-9. PubMed ID: 12491501 [TBL] [Abstract][Full Text] [Related]
3. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation. Johansen J; Overgaard J; Overgaard M Acta Oncol; 2007; 46(4):525-33. PubMed ID: 17497320 [TBL] [Abstract][Full Text] [Related]
4. [Complications of irradiation in combined irradiation and chemotherapy of breast cancer]. von der Maase H Ugeskr Laeger; 1978 Jul; 140(28):1678-80. PubMed ID: 695029 [No Abstract] [Full Text] [Related]
5. Combination chemotherapy as an adjuvant treatment in operable breast cancer. Bonadonna G; Brusamolino E; Valagussa P; Rossi A; Brugnatelli L; Brambilla C; De Lena M; Tancini G; Bajetta E; Musumeci R; Veronesi U N Engl J Med; 1976 Feb; 294(8):405-10. PubMed ID: 1246307 [TBL] [Abstract][Full Text] [Related]
6. Local control of breast cancer with tumorectomy plus radiotherapy or radiotherapy alone. Ghossein NA; Stacey P; Alpert RT; Ager PJ; Krishnaswamy V Radiology; 1976 Nov; 121(2):455-9. PubMed ID: 824680 [TBL] [Abstract][Full Text] [Related]
7. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. Overgaard M; Hansen PS; Overgaard J; Rose C; Andersson M; Bach F; Kjaer M; Gadeberg CC; Mouridsen HT; Jensen MB; Zedeler K N Engl J Med; 1997 Oct; 337(14):949-55. PubMed ID: 9395428 [TBL] [Abstract][Full Text] [Related]
8. [Evaluation of the toxicity of precautional chemotherapy with cyclophosphamide, methotrexate and 5-fluorouracil (CMF) in carcinoma of the breast in the first 700 treatment cycles]. Sismondi P; Zola P; Galletto L; De Giovanni D; Giardina G Minerva Ginecol; 1979; 31(7-8):563-8. PubMed ID: 481814 [No Abstract] [Full Text] [Related]
9. Surgery and adjuvant chemotherapy in the treatment of operable breast cancer. Rossi A; Valagussa P; Bonadonna G Prog Clin Biol Res; 1977; 12():391-404. PubMed ID: 335401 [No Abstract] [Full Text] [Related]
10. The case for adjuvant CMF chemotherapy in breast cancer. Has it been made? Levitt SH; Potish RA Cancer Clin Trials; 1981; 4(4):363-9. PubMed ID: 7032731 [TBL] [Abstract][Full Text] [Related]
11. [Simultaneous combined radio-/chemotherapy of locally recurring breast cancer]. Renner H; Lang C; Ziegler K Strahlentherapie; 1984 Jul; 160(7):421-4. PubMed ID: 6464045 [TBL] [Abstract][Full Text] [Related]
12. Risk of acute leukemia following epirubicin-based adjuvant chemotherapy: a report from the National Cancer Institute of Canada Clinical Trials Group. Crump M; Tu D; Shepherd L; Levine M; Bramwell V; Pritchard K J Clin Oncol; 2003 Aug; 21(16):3066-71. PubMed ID: 12915595 [TBL] [Abstract][Full Text] [Related]
13. [Esthetic results of the conservative treatment in breast carcinoma]. Moro G Radiol Med; 1995 Oct; 90(4):481-5. PubMed ID: 8552828 [TBL] [Abstract][Full Text] [Related]
14. [Leukemia in patients with breast carcinoma after adjuvant chemotherapy and/or postoperative radiotherapy]. Sack H Strahlenther Onkol; 1995 Jul; 171(7):420-1. PubMed ID: 7631268 [No Abstract] [Full Text] [Related]
15. Simultaneous adjuvant radiation therapy and chemotherapy in high-risk breast cancer--toxicity and dose modification: a Transtasman Radiation Oncology Group Multi-Institution study. Denham JW; Hamilton CS; Christie D; O'Brien M; Bonaventura A; Stewart JF; Ackland SP; Lamb DS; Spry NA; Dady P Int J Radiat Oncol Biol Phys; 1995 Jan; 31(2):305-13. PubMed ID: 7836084 [TBL] [Abstract][Full Text] [Related]
16. A phase III randomized trial comparing adjuvant concomitant chemoradiotherapy versus standard adjuvant chemotherapy followed by radiotherapy in operable node-positive breast cancer: final results. Rouëssé J; de la Lande B; Bertheault-Cvitkovic F; Serin D; Graïc Y; Combe M; Leduc B; Lucas V; Demange L; Nguyen TD; Castèra D; Krzisch C; Villet R; Mouret-Fourme E; Garbay JR; Noguès C; Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1072-80. PubMed ID: 16504757 [TBL] [Abstract][Full Text] [Related]
17. Anticipatory vomiting in women receiving cyclophosphamide, methotrexate, and 5-FU (CMF) adjuvant chemotherapy for breast carcinoma. Wilcox PM; Fetting JH; Nettesheim KM; Abeloff MD Cancer Treat Rep; 1982 Aug; 66(8):1601-4. PubMed ID: 7049385 [TBL] [Abstract][Full Text] [Related]
18. Concurrent cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy and radiotherapy for early breast carcinoma. Livi L; Saieva C; Borghesi S; Paoletti L; Meattini I; Rampini A; Petrucci A; Scoccianti S; Paiar F; Cataliotti L; Leonulli BG; Bianchi S; Biti GP Int J Radiat Oncol Biol Phys; 2008 Jul; 71(3):705-9. PubMed ID: 18191333 [TBL] [Abstract][Full Text] [Related]
19. Integration of full-dose adjuvant chemotherapy with definitive radiotherapy for primary breast cancer: four-year update. Glick JH; Fowble BL; Haller DG; Rosato EF; Mackie JA; Weiler C; Glover DJ; Fox KR; Hurwitz S; Goodman RL NCI Monogr; 1988; (6):297-301. PubMed ID: 3352774 [TBL] [Abstract][Full Text] [Related]
20. Randomized trial comparing cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) with rotational CMF, epirubicin and vincristine as primary chemotherapy in operable breast carcinoma. Cocconi G; Di Blasio B; Boni C; Bisagni G; Ceci G; Rondini E; Bella M; Leonardi F; Savoldi L; Camisa R; Bruzzi P Cancer; 2002 Jul; 95(2):228-35. PubMed ID: 12124820 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]